Lipids for parenteral nutrition in neonates

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 2, 2011, Pages 145-150

  Deshpande, Girish ^a,b   Simmer, Karen ^b,c  

^a NEPEAN HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

lipid emulsions; neonate; parenteral nutrition; preterm neonate

Indexed keywords

ARACHIDONIC ACID; CLINOLEIC; ESSENTIAL FATTY ACID; FISH OIL; ICOSANOID; INTRALIPID; ISOPROSTANE DERIVATIVE; LINOLEIC ACID; LINOLENIC ACID; LIPID EMULSION; LIPOFUNDIN; LIPOPLUS; OLEIC ACID; OLIVE OIL; OMEGAVEN; POLYUNSATURATED FATTY ACID; SMOFLIPID; SOYBEAN OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DEVELOPMENT; CHEMICAL COMPOSITION; CHILD NUTRITION; CHOLESTASIS; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ESSENTIAL FATTY ACID DEFICIENCY; FAT INTAKE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HUMAN; ICOSANOID METABOLISM; IMMUNOMODULATION; INFLAMMATION; LIPID PEROXIDATION; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PARENTERAL NUTRITION; TRIACYLGLYCEROL BLOOD LEVEL;

DRUG STABILITY; FAT EMULSIONS, INTRAVENOUS; HUMANS; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; NUTRITIONAL REQUIREMENTS; PARENTERAL NUTRITION;

GLYCINE MAX;

EID: 79952036749     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3283434562     Document Type: Article

References (50)

1. Wessel JJ, Kocoshis SA. Nutritional management of infants with short bowel syndrome. Semin Perinatol 2007;31:104-111. (Pubitemid 46616963)
2. Driscoll DF. Lipid injectible emulsions: 2006. Nutr Clin Pract 2006;21:381-386.
3. Uauy R, Hoffman DR, Peirano P, et al. Essential fatty acids in visual and brain development. Lipids 2001;36:885-895. (Pubitemid 33065189)
4. McNamara RK, Carlson SE. Role of omega-3 fatty acids in brain development and function and function: potential implication for pathogenesis and prevention of psychopathology. Prostagklandians Leukot Essent Fatty Acids 2006;75:329-349. (Pubitemid 44442917)
5. Yaqoob P. Fatty acids and the immune system: from basic science to clinical applications. Proc Nutr Soc 2004;63:89-104. (Pubitemid 38543877)
6. Eritsland J. Safety considerations of polyunsaturated fatty acids. Am J Clin Nutr 2000;71 (Suppl 1):197S-201S. (Pubitemid 30046116)
7. Sweeney B, Puri P, Reen DJ. Modulation of immune cell function by polyunsaturated fatty acids. Pediatr Surg Int 2005;21:335-340. (Pubitemid 40674782)
8. Drenckpohl D, McConnell C, Gaffney S, et al. Randomized trial of very low birth weight infants receiving higher rates of infusion of intravenous fat emulsions during the first week of life. Pediatrics 2008;122:743-751.
9. Embleton N, Pang N, Cooke R. Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants? Pediatrics 2001;107:270-273. (Pubitemid 32121240)
10. Simmer K, Rao SC. Early introduction of lipids to parenterally fed preterms infants. Cochr Rev 2005:CD005256.
11. Brans YW, Andrew DS, Carrillo DW, et al. Tolerance of fat emulsions in very low birthweight neonates: effect of birth weight on plasma lipid concentrations. Am J Perinatol 1990;7:114-117. (Pubitemid 20138154)
12. Koletzko B, Goulet O, Hunt J, et al. Parenteral Nutrition GuidelinesWorking Group;European Society for Clinical Nutrition and Metabolism;European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN);European Society of Paediatric Research (ESPR). 1. Guidelines onPaediatricParenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005;41 (Suppl 2):S1-S87.
13. A.S.P.E.N Board of directors and the clinical guideline task force. Guidelines for the use of parenteral and enteral nutrition in adult and paediatric patients. J Parenter Enteral Nutr 2002;26 (Suppl 1):106SA-107SA.
14. Kluttgens BU, Sewell GJ, Nunn AJ. Current clinical practice in neonatal and pediatric parenteral nutrition in Europe. Eur J Hosp Phram 2003;9:122-126.
15. Solassol C, Joyeux H, Etco L, et al. New technique for long term intravenous feeding: an artificial gut in 75 patients. Ann Surg 1974;179:519.
16. Hardy G, Puzovic M. Formulation, stability, and administration of parenteral nutrition with new lipid emulsions. Nutr Clin Pract 2009;24:616-625.
17. Costello I, Powell C, Williams AF. Sodium glycerophosphate in the treatment of neonatal hypophosphataemia. Arch Dis Child Fetal Neonatal Ed 1995;73:F44-F45.
18. Ribeiro Dde O, Lobo BW, Volpato NM, et al. Influence of the calcium concentration in the presence of organic phosphorus on the physicochemical compatibility and stability of all-in-one admixtures for neonatal use. Nutr J 2009;26:51. In-vivo study about stability of all-in-one mixtures for neonatal use.
19. Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsion for clinical use. J Parenter Enteral Nut 2006;30:351-367.
20. Sala-Vila A, Barbosa VM, Calder PC. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care 2007;10:165-174. (Pubitemid 46220308)
21. Goulet O, de Potter S, Antébi H, et al. Long-term efficacy and safety of a new olive oil-based intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr 1999;70:338-345. (Pubitemid 29407153)
22. Deshpande GC, Simmer K, Mori T, Croft K. Parenteral lipid emulsions based on olive oil compared with soybean oil in preterm (28 weeks' gestation) neonates: a randomised controlled trial. J Pediatr Gastroenterol Nutr 2009;49: 619-625.
23. Webb AN, Hardy P, Peterkin M, et al. Tolerability and safety of olive oil-based lipid emulsion in critically ill neonates: a blinded randomized trial. Nutrition 2008;24:1057-1064.
24. Roggero P, Mosca F, GianǹML, et al. F2-isoprostanes and total radicaltrapping antioxidant potential in preterm infants receiving parenteral lipid emulsions. Nutrition 2010;26:551-555.
25. Van Kempen AA, van der Crabben SN, Ackermans MT, et al. Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile. Am J Physiol Endocrinol Metab 2006;290:E723-E730.
26. Kinsella JE, Broughton S, Whelan JW, et al. Dietary fatty acids: interaction and possible needs in relation to eicosanoid synthesis. J Nutr Biochem 1995;1:123-141. (Pubitemid 20227773)
27. Gawecka A, Michalkiewicz J, Kornacka MK, et al. Immunologic properties differ in preterm infants fed olive oil vs soy-based lipid emulsions during parenteral nutrition. J Parenter Enteral Nutr 2008;32:448-453. (Pubitemid 351875940)
28. Grimm H, Mertes N, Goeters C, et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr 2006;45:55-60. (Pubitemid 43221285)
29. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutritionassociated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 2006;118:e197-e201. (Pubitemid 46071136)
30. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008;121:678-686.
31. Tomsits E, Pataki M, Tölgyesi A, et al. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010. [Epub ahead of print]
32. De Meijer VE, Gura KM, Meisel JA, et al. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg 2010;145:547-551.
33. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996;25:57-74. (Pubitemid 26245475)
34. Varsila E, Hallman M, Andersson S. Free-radical-induced lipid peroxidation during the early neonatal period. Acta Paediatr 1994;83:692-695. (Pubitemid 24248816)
35. Saugstad OD. Oxidative stress in the newborn: a 30-year prospective. Biol Neonate 2005;88:228-236. (Pubitemid 41433555)
36. Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr 2010;64:940-947.
37. Mirtallo JM, Dasta JF, Kleinschmidt KC, Varon J. State of the art review: intravenous fat emulsions - current applications, safety profile, and clinical implications. Ann Pharmacother 2010;44:688-700.
38. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 2007;85:1171-1184. (Pubitemid 46740457)
39. De Nardi L, Bellinati-Pires R, Torrinhas RS, et al. Effect of fish oil containing parenteral lipid emulsions on neutrophil chemotaxis and resident-macrophages' phagocytosis in rats. Clin Nutr 2008;27:283-288.
40. Antébi H, Mansoor O, Ferrier C, et al. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. J Parenter Enteral Nutr 2004;28: 142-148.
41. Schade I, Rohm KD, Schellhaass A, et al. Inflammatory response in patients requiring parenteral nutrition: comparison of a new fish-oil-containing emulsion (SMOF) versus an olive/soybean oil-based formula. Crit Care 2008;12 (Suppl 2):144. doi: 10.1186/cc6365.
42. Jacintho TM, Gotho H, Gidlund M, et al. Anti-inflammatory effect of parenteral fish oil lipid emulsion on human activated mononuclear leukocytes. Nutr Hosp 2009;24:288-296.
43. Diamond IR, Pencharz PB, Wales PW. Omega-3 lipids for intestinal failure associated liver disease. Semin Pediatr Surg 2009;18:239-245.
44. Diamond IR, Sterescu A, Pencharz PB, et al. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009;48:209-215.
45. Rollins MD, Scaife ER, Jackson WD, et al. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome. Nutr Clin Pract 2010;25:199-204.
46. Nasr A, Diamond IR, de Silva NT, Wales PW. Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction? J Pediatr Surg 2010;45:980-986.
47. Costa S, Maggio L, Sindico P, et al. Preterm small for gestational age infants are not at higher risk for parenteral nutrition-associated cholestasis. J Pediatr 2010;156:575-579.
48. Deshpande G, Simmer K, Madhur R, et al. Efficacy and safety of a novel fish oil based lipid emulsion (SMOF1) compared with olive oil based lipid emulsion (Clinoleic1) in term and near-term (>34 weeks) neonates: a randomised controlled trial. http://www.anzctr.org.au/trialview.aspx?ID=83596. [Accessed .24. September 2010] .
49. Deshpande G, Simmer K, Deshmukh M, et al. Efficacy and safety of a new fish oil based lipid emulsion (SMOFlipid) compared with olive oil based lipid emulsion (Clinoleic) in pre term (<30 weeks) neonates: a randomised controlled trial http://www.anzctr.org.au/trialview.aspx?ID=32086246. [Accessed 24 September 2010]
50. Makrides M, Gibson RA, McPhee AJ, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009;301:175-182.